Basel Medical GroupBMGL
13F holders, Q2 2026 (June 30)2holders
$6.89avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Basel Medical Group Ltd. (BMGL) in their 13F filings. The largest holders were UBS Group AG ($3K) and Coston, McIsaac & Partners ($0).
- Company
- Basel Medical Group Ltd.
- CUSIP
- G0864B111
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 0 | $0 |
Ownership 2 holders
| UBS Group AG | 0.00% | New | 495 | $3K |
| Coston, McIsaac & Partners | 0.00% | New | 4 | $0 |
"% of holder's portfolio" is BMGL's weight in each manager's 13F, not the share of Basel Medical Group Ltd. the manager owns.